Transcatheter Mitral Intervention
With the recent approval for transcatheter aortic valve replacement (TAVR) across all risk profiles, reintervention is likely to become common practice. As surgeons treat younger, fitter patients with longer life expectancies, complications such as thrombosis,...
This multisociety European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) consensus statement addresses three mechanical complications of acute myocardial infarction: ventricular free-wall rupture, pseudoaneurysm, and papillary muscle rupture....
With the recent approval for transcatheter aortic valve replacement (TAVR) across all risk profiles, reintervention is likely to become common practice. As surgeons treat younger, fitter patients with longer life...
A recently published article showed the benefit of TEER compared to mitral valve surgery in older, sicker patients with a high risk in surgery. Based on the French administrative hospital...
In this article, the authors evaluated the practice trends and three-year outcomes following transcatheter edge-to-edge repair (TEER) and surgical repair for degenerative MR in the United States. Medicare and Medicaid...
On May 25, 2021, Dr. David Heimansohn successfully performed the first surgical implantation of biopolymer Tria™ heart valve in a patient with mitral valve disease at Ascension St. Vincent Hospital,...
In the special April issue of JACC Imaging focusing on secondary mitral regurgitation (SMR), a number of articles on outcomes after transcatheter edge-to-edge repair (TEER) are reported. Specifically, the concept...
In this article, Kilcoyne et al discuss the current status of training cardiothoracic surgery trainees in structural heart disease and propose a new core curriculum for training surgeons in structural...
An interesting pilot experiment on attempting to quantify the optimum disposition of neochordae in transapical intervention for severe mitral regurgitation.
...The authors address appropriate use of the transcatheter clip to treat degenerative mitral regurgitation in elderly low to moderate risk patients. Their analysis shows that the transcatheter approach had slightly...
In an era of increased use of MitraClip, surgical mitral valve repair still offers a durable solution. Tirone David and colleages report 1,234 consecutive patients who had mitral valve repair...
Patient Care and General Interest The American Heart Association published a statement advocating for a holistic care approach for patients with Fontan circulation, noting that these patients are living longer...
Abbott announced that its fourth-generation MitraClip device, MitraClip G4, was approved by the US Food and Drug Administration on July 15, 2019, to treat mitral regurgitation (MR) in a wider...


